Sinopharm Group Co. Ltd. (SHTDY)
USD 13.79
(0.0%)
USD 13.79
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 17.25 Billion CNY | 15.36% |
| 2022 | 14.95 Billion CNY | 28.18% |
| 2021 | 11.66 Billion CNY | -4.06% |
| 2020 | 12.16 Billion CNY | 6.03% |
| 2019 | 11.47 Billion CNY | 128.53% |
| 2018 | 5.01 Billion CNY | -9.16% |
| 2017 | 5.52 Billion CNY | -50.38% |
| 2016 | 11.13 Billion CNY | 1730.88% |
| 2015 | 608.19 Million CNY | -85.6% |
| 2014 | 4.22 Billion CNY | 2.14% |
| 2013 | 4.13 Billion CNY | -20.37% |
| 2012 | 5.19 Billion CNY | 0.18% |
| 2011 | 5.18 Billion CNY | 5601.16% |
| 2010 | 90.9 Million CNY | 81.8% |
| 2009 | 50 Million CNY | -61.54% |
| 2008 | 130 Million CNY | -17.58% |
| 2007 | 157.72 Million CNY | -11.25% |
| 2006 | 177.72 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.92 Billion CNY | 11.42% |
| 2024 Q1 | 14.29 Billion CNY | 3.32% |
| 2023 Q3 | 20.84 Billion CNY | 12.45% |
| 2023 FY | 17.25 Billion CNY | 15.36% |
| 2023 Q4 | 17.25 Billion CNY | -17.21% |
| 2023 Q2 | 18.53 Billion CNY | -2.61% |
| 2023 Q1 | 19.03 Billion CNY | 27.24% |
| 2022 Q2 | 13.74 Billion CNY | 15.82% |
| 2022 FY | 14.95 Billion CNY | 28.18% |
| 2022 Q3 | 16.29 Billion CNY | 18.57% |
| 2022 Q4 | 14.95 Billion CNY | -8.21% |
| 2022 Q1 | 11.86 Billion CNY | 1.69% |
| 2021 Q4 | 11.66 Billion CNY | -17.22% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 14.09 Billion CNY | 3.62% |
| 2021 FY | 11.66 Billion CNY | -4.06% |
| 2021 Q2 | 13.6 Billion CNY | 0.0% |
| 2020 Q3 | 14.36 Billion CNY | 26.51% |
| 2020 Q2 | 11.35 Billion CNY | -11.75% |
| 2020 Q1 | 12.86 Billion CNY | 12.15% |
| 2020 FY | 12.16 Billion CNY | 6.03% |
| 2020 Q4 | 12.16 Billion CNY | -15.32% |
| 2019 Q1 | 5.46 Billion CNY | 8.91% |
| 2019 Q2 | 8.32 Billion CNY | 52.27% |
| 2019 Q3 | 12.29 Billion CNY | 47.68% |
| 2019 Q4 | 11.47 Billion CNY | -6.69% |
| 2019 FY | 11.47 Billion CNY | 128.53% |
| 2018 Q2 | 1.55 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 5.01 Billion CNY | -9.16% |
| 2018 Q4 | 5.01 Billion CNY | 0.0% |
| 2017 Q3 | 5.59 Billion CNY | -33.64% |
| 2017 Q4 | 5.52 Billion CNY | -1.24% |
| 2017 FY | 5.52 Billion CNY | -50.38% |
| 2017 Q2 | 8.43 Billion CNY | 0.0% |
| 2017 Q1 | 8.43 Billion CNY | -24.29% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 11.13 Billion CNY | 0.0% |
| 2016 Q3 | 11.13 Billion CNY | 19.6% |
| 2016 Q2 | 9.31 Billion CNY | 0.0% |
| 2016 FY | 11.13 Billion CNY | 1730.88% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 608.19 Million CNY | -85.6% |
| 2015 Q3 | 608.19 Million CNY | 293.33% |
| 2015 Q2 | 154.62 Million CNY | 0.0% |
| 2015 Q4 | 608.19 Million CNY | 0.0% |
| 2014 Q1 | 4.32 Billion CNY | 4.57% |
| 2014 Q4 | 4.22 Billion CNY | 0.0% |
| 2014 FY | 4.22 Billion CNY | 2.14% |
| 2014 Q3 | 4.22 Billion CNY | -2.32% |
| 2014 Q2 | 4.32 Billion CNY | 0.0% |
| 2013 Q2 | 7.2 Billion CNY | 0.0% |
| 2013 Q1 | 7.2 Billion CNY | 38.72% |
| 2013 FY | 4.13 Billion CNY | -20.37% |
| 2013 Q4 | 4.13 Billion CNY | 0.0% |
| 2013 Q3 | 4.13 Billion CNY | -42.6% |
| 2012 FY | 5.19 Billion CNY | 0.18% |
| 2012 Q2 | 5.22 Billion CNY | 0.0% |
| 2012 Q4 | 5.19 Billion CNY | 0.0% |
| 2011 FY | 5.18 Billion CNY | 5601.16% |
| 2011 Q4 | 5.18 Billion CNY | 0.0% |
| 2011 Q2 | 2.18 Billion CNY | 0.0% |
| 2010 FY | 90.9 Million CNY | 81.8% |
| 2010 Q4 | 90.9 Million CNY | 0.0% |
| 2010 Q2 | 116 Million CNY | 0.0% |
| 2009 FY | 50 Million CNY | -61.54% |
| 2009 Q4 | 50 Million CNY | 0.0% |
| 2009 Q2 | 60 Million CNY | 0.0% |
| 2008 Q4 | 130 Million CNY | 0.0% |
| 2008 FY | 130 Million CNY | -17.58% |
| 2007 FY | 157.72 Million CNY | -11.25% |
| 2006 FY | 177.72 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| China Medicine Corporation | - USD | -Infinity% |
| DH Enchantment Inc. | - USD | -Infinity% |
| Exlites Holdings International, Inc. | - USD | -Infinity% |
| Itonis, Inc. | - USD | -Infinity% |
| One Step Vending Corp. | - USD | -Infinity% |
| MediPal Holdings Corporation | - USD | -Infinity% |
| PD-Rx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharmagen, Inc. | 770.31 USD | -2239991332.021% |
| Suzuken Co., Ltd. | - USD | -Infinity% |